The health ministry said Monday it has found documents with the names or initials of 118 out of 418 people who developed hepatitis C from a tainted blood product, reversing its earlier claim that it had no data to confirm any of their identities.</PARAGRAPH>
<PHOTO>
<TABLE WIDTH='250' ALIGN='RIGHT' BORDER='0'>
<TR>
<TD><IMG ALT='News photo' BORDER='0' SRC='../images/photos2007/nn20071023a3a.jpg' WIDTH='250' HEIGHT='163'/></TD>
</TR>
<TR>
<TD><FONT SIZE='1'><B>Mitsubishi Tanabe Pharma Corp. President Natsuki Hayama –
and Vice President Takeshi
Komine (right) face reporters at the health ministry Monday.
KYODO PHOTO
The 118 are among 418 hepatitis C patients infected by tainted fibrinogen made by the now-defunct blood product maker Green Cross Corp.
In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you can help us get the story right.